Discounted Cash Flow (DCF) Analysis Levered
Health Discovery Corporation (HDVY)
$0.0004
0.00 (0.00%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
Revenue | 0.04 | 0.04 | 0.04 | 1.52 | 0 | 0.01 | 0.08 | 0.75 | 6.79 | 61.58 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | -0.47 | -0.31 | -0.28 | 2.20 | -1.38 | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | - | - | - | - | - | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
Weighted Average Cost Of Capital
Share price | $ 0.0,004 |
---|---|
Beta | 2.348 |
Diluted Shares Outstanding | 397.63 |
Cost of Debt | |
Tax Rate | 0.00 |
After-tax Cost of Debt | 4.72% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 14.891 |
Total Debt | 0.21 |
Total Equity | 0.16 |
Total Capital | 0.37 |
Debt Weighting | 57.13 |
Equity Weighting | 42.87 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
Revenue | 0.04 | 0.04 | 0.04 | 1.52 | 0 | 0.01 | 0.08 | 0.75 | 6.79 | 61.58 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | -0.47 | -0.31 | -0.28 | 2.20 | -1.38 | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | -2.54 | -23.09 | -209.55 | -1,901.87 | -17,261.27 |
WACC | ||||||||||
PV LFCF | -2.33 | -19.40 | -161.46 | -1,343.38 | -11,177.56 | |||||
SUM PV LFCF | -12,704.14 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 9.08 |
Free cash flow (t + 1) | -17,606.49 |
Terminal Value | -248,679.30 |
Present Value of Terminal Value | -161,032.67 |
Intrinsic Value
Enterprise Value | -173,736.81 |
---|---|
Net Debt | -0.70 |
Equity Value | -173,736.10 |
Shares Outstanding | 397.63 |
Equity Value Per Share | -436.93 |